This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damond, F.
Right arrow Articles by Brun-Vezinet, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damond, F.
Right arrow Articles by Brun-Vezinet, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 4234-4236, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4234-4236.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Improved Sensitivity of Human Immunodeficiency Virus Type 2 Subtype B Plasma Viral Load Assay

Florence Damond,1,2* Gilles Collin,1,2 Diane Descamps,1,2 Sophie Matheron,1 Sophie Pueyo,3 Audrey Taieb,3 Pauline Campa,4 Antoine Benard,3 Geneviève Chêne,3 and Francoise Brun-Vezinet1,2

Hôpital Bichat Claude Bernard, Paris, France,1 INSERM U552, Paris, France,2 INSERM U330, Bordeaux, France,3 Hôpital Saint Antoine, Paris, France4

Received 27 January 2005/ Accepted 23 April 2005

We developed a new assay for human immunodeficiency virus type 2 plasma RNA quantification based on a previous format. The new version performed significantly better than the original regarding the detection of subtype B, allowing the detection of 14 out of 36 plasma RNAs in the subtype B-infected patients not detected with the original version.

* Corresponding author. Mailing address: Laboratoire de Virologie, Hôpital Bichat Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France. Phone: 33 1 40 25 61 51. Fax: 33 1 40 25 67 69. E-mail: florence.damond{at}bch.ap-hop-paris.fr.

Journal of Clinical Microbiology, August 2005, p. 4234-4236, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4234-4236.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Roquebert, B., Damond, F., Collin, G., Matheron, S., Peytavin, G., Benard, A., Campa, P., Chene, G., Brun-Vezinet, F., Descamps, D., on behalf of the French ANRS HIV-2 Cohort (ANRS CO, (2008). HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro. J Antimicrob Chemother 62: 914-920 [Abstract] [Full Text]  
  • Damond, F., Benard, A., Ruelle, J., Alabi, A., Kupfer, B., Gomes, P., Rodes, B., Albert, J., Boni, J., Garson, J., Ferns, B., Matheron, S., Chene, G., Brun-Vezinet, F., for the ACHIEV2E (a Collaboration on HIV-2 Infecti, (2008). Quality Control Assessment of Human Immunodeficiency Virus Type 2 (HIV-2) Viral Load Quantification Assays: Results from an International Collaboration on HIV-2 Infection in 2006. J. Clin. Microbiol. 46: 2088-2091 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»